These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10969352)
1. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. Jones JL; Hanson DL; Dworkin MS; Jaffe HW J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352 [TBL] [Abstract][Full Text] [Related]
2. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. Rabkin CS; Testa MA; Huang J; Von Roenn JH J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216 [TBL] [Abstract][Full Text] [Related]
4. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626 [TBL] [Abstract][Full Text] [Related]
5. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Ives NJ; Gazzard BG; Easterbrook PJ J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320 [TBL] [Abstract][Full Text] [Related]
6. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. Jones JL; Hanson DL; Dworkin MS; Ward JW; Jaffe HW J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S11-7. PubMed ID: 10430212 [TBL] [Abstract][Full Text] [Related]
7. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. Glesby MJ; Hoover DR; Weng S; Graham NM; Phair JP; Detels R; Ho M; Saah AJ J Infect Dis; 1996 Jun; 173(6):1477-80. PubMed ID: 8648224 [TBL] [Abstract][Full Text] [Related]
8. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. Grulich AE; Li Y; McDonald AM; Correll PK; Law MG; Kaldor JM AIDS; 2001 Mar; 15(5):629-33. PubMed ID: 11317001 [TBL] [Abstract][Full Text] [Related]
9. Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort. Dore GJ; Li Y; Grulich AE; Hoy JF; Mallal SA; Mijch AM; French MA; Cooper DA; Kaldor JM AIDS; 1996 Oct; 10(12):1401-6. PubMed ID: 8902070 [TBL] [Abstract][Full Text] [Related]
10. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era. Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433 [TBL] [Abstract][Full Text] [Related]
11. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. Rezza G; Dorrucci M; Serraino D; Andreoni M; Giuliani M; Zerboni R; Sarmati L; Colangeli V; Salassa B; Monini P; Ensoli B; Pezzotti P AIDS; 2000 Jul; 14(11):1647-53. PubMed ID: 10983652 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America. Castilho JL; Kim A; Jenkins CA; Grinsztejn B; Gotuzzo E; Fink V; Padgett D; Belaunzaran-Zamudio PF; Crabtree-Ramírez B; Escuder MM; Souza RA; Tenore SB; Pimentel SR; Ikeda MLR; de Alencastro PR; Tupinanbas U; Brites C; Luz E; Netto J; Cortes CP; Grangeiro A; Shepherd BE; McGowan CC; J Int AIDS Soc; 2021 Jan; 24(1):e25658. PubMed ID: 33405281 [TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan. Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda. Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164 [TBL] [Abstract][Full Text] [Related]
16. Facing up to the ongoing challenge of Kaposi's sarcoma. Robey RC; Bower M Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya. Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092 [TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma: a reevaluation. Orfanos CE; Husak R; Wölfer U; Garbe C Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146 [TBL] [Abstract][Full Text] [Related]